Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.

Sep.12.2025
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing

Key Points

 

  • Growth target: Imperial aims to sustain double-digit net revenue growth in Next-Generation Products (NGP) for the next five years; the company says it has delivered double-digit growth over the past two years with share gains across its three NGP categories.

 

  • Go-to-market: Primarily organic growth, supplemented by small bolt-on M&A; entry focus on markets where the category is established and route-to-market is in place.

 

  • UK/France shift: Following disposable vape bans, the business has pivoted to rechargeable pod systems; UK vapor share has doubled in the past 12 months and exceeded 10% in H1.

 

  • U.S. oral nicotine: ZONE, launched in Feb 2024, has reached about 3% market share in ~18 months; a more moist pouch option has been introduced, with emphasis on regulatory compliance.

 

  • Portfolio mix: NGP revenue is roughly 75% vapor / 25% oral nicotine; CEO Stefan Bomhard says new launches will be prioritized only once categories reach sufficient scale (e.g., delaying pouches in the UK until the market matures).

 


 

2Firsts, September 12, 2025 — In a fireside chat at the Barclays Global Consumer Staples Conference, Imperial Brands CEO Stefan Bomhard outlined the company’s 2025–2030 strategy and direction for Next-Generation Products (NGP). He said Imperial has “reset” its NGP business over the past five years, delivering double-digit growth in the last two and gaining share across its three NGP categories. The group is targeting another five years of double-digit NGP growth.

 

On market selection and expansion, Bomhard said Imperial prioritizes countries where the category is already established and distribution is in place, launching differentiated propositions against clear consumer needs. He reiterated Imperial’s positioning as the world’s fourth-largest tobacco company.

 

Addressing policy shifts in Europe, he noted that after the disposable-vape bans in the UK and France, Imperial transitioned its offers to rechargeable pod systems. Over the past 12 months, the company’s UK vapor share has doubled, and in the first half it surpassed 10% for the first time. Pods will remain the core of its UK and French supply strategy.

 

In the United States, the ZONE nicotine-pouch brand, launched in February 2024, has reached around 3% market share in roughly 18 months. Imperial has added a more moist pouch option and stressed adherence to regulatory processes. As for introducing pouches in the UK, Bomhard described the category as “small and fragmented,” indicating Imperial will wait for the market to stabilize before entering.

 

Imperial’s NGP mix is about 75% vapor and 25% oral nicotine. The company will expand in a disciplined manner—largely organically—with small acquisitions considered only as supplements, keeping a tight focus on consumer insight and execution in the trade.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
According to Reuters, the U.S. vaping market has recently seen an increase in products marketed as “Made in America” amid the Trump administration’s stronger enforcement against unauthorized vape brands and increased trade tariff pressure on Chinese goods. Since October 2025, at least eight new vape brands highlighting American credentials have entered the U.S. market, and none of them has authorization for sale. Brands mentioned by Reuters include Maxus Star and OneTank.
Apr.08
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia will strengthen surveillance of vapes amid growing concerns over drug-laced e-cigarettes. The National Food and Drug Monitoring Agency, or BPOM, will soon take charge of monitoring nationwide vape distribution and said it will work with the National Narcotics Agency, or BNN. BNN recently floated a plan to completely ban e-cigarettes, saying a total ban was the only way to prevent liquid narcotics.
May.11 by 2FIRSTS.ai
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
The FDA issued warning letters to eight retailers selling unauthorized nicotine pouches and dissolvable tobacco products resembling candy, breath strips and cough drops. The action highlights rising scrutiny of packaging, youth appeal and accidental ingestion risks, as the agency clarifies enforcement priorities for unauthorized ENDS and nicotine pouch products while maintaining PMTA as the legal market pathway.
Special Report
May.21